October 25, 2014 7:54 PM ET

Pharmaceuticals

Company Overview of Edge Therapeutics, Inc.

Executive Profile

R. Loch MacDonald M.D., Ph.D.

Co-Founder, Chief Scientific Officer and Director, Edge Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. R. Loch MacDonald, M.D., Ph.D. co-founded Edge Therapeutics, Inc. in 2009 and serves as Chief Scientific Officer. Dr. Macdonald is widely considered as a top expert in the world on cerebral vasospasm. His 20 years of unrelenting research has led Edge Therapeutics to its first product, NimoGel, to cure vasospasm. Recent articles published by Dr. Macdonald are Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1), ...

Corporate Headquarters

139 South Street
New Providence, New Jersey 07974

United States

Phone: 800-208-3343
Fax: 800-208-3433

Board Members Memberships

Co-Founder, Chief Scientific Officer and Director

Education

Unknown/Other Education
University of Toronto
PhD
University Of Alberta

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edge Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.